A detailed history of Tcg Advisory Services, LLC transactions in Replimune Group, Inc. stock. As of the latest transaction made, Tcg Advisory Services, LLC holds 25,367 shares of REPL stock, worth $260,011. This represents 0.01% of its overall portfolio holdings.

Number of Shares
25,367
Holding current value
$260,011
% of portfolio
0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025

BUY
$6.92 - $10.38 $175,539 - $263,309
25,367 New
25,367 $235,000

Others Institutions Holding REPL

About Replimune Group, Inc.


  • Ticker REPL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,306,700
  • Market Cap $505M
  • Description
  • Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...
More about REPL
Track This Portfolio

Track Tcg Advisory Services, LLC Portfolio

Follow Tcg Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tcg Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tcg Advisory Services, LLC with notifications on news.